本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiniksa Pharmaceuticals Ltd.

75.15
-1.4300-1.87%
盤後75.150.00000.00%19:30 EDT
成交量:48.89萬
成交額:3,669.69萬
市值:58.64億
市盈率:75.91
高:76.63
開:76.46
低:74.47
收:76.58
52周最高:82.94
52周最低:35.20
股本:7,802.40萬
流通股本:3,994.15萬
量比:0.83
換手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
淨資產收益率:14.04%
總資產收益率:8.05%
市淨率:8.96
市盈率(LYR):100.20

資料載入中...

2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/28

重要事件披露

Form 8-K - Current report
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/28

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/28

重要事件披露

Form 8-K - Current report
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities